229 related articles for article (PubMed ID: 23576562)
1. Pak1 kinase links ErbB2 to β-catenin in transformation of breast epithelial cells.
Arias-Romero LE; Villamar-Cruz O; Huang M; Hoeflich KP; Chernoff J
Cancer Res; 2013 Jun; 73(12):3671-82. PubMed ID: 23576562
[TBL] [Abstract][Full Text] [Related]
2. A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells.
Arias-Romero LE; Villamar-Cruz O; Pacheco A; Kosoff R; Huang M; Muthuswamy SK; Chernoff J
Oncogene; 2010 Oct; 29(43):5839-49. PubMed ID: 20711231
[TBL] [Abstract][Full Text] [Related]
3. β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression.
Schade B; Lesurf R; Sanguin-Gendreau V; Bui T; Deblois G; O'Toole SA; Millar EK; Zardawi SJ; Lopez-Knowles E; Sutherland RL; Giguère V; Kahn M; Hallett M; Muller WJ
Cancer Res; 2013 Jul; 73(14):4474-87. PubMed ID: 23720052
[TBL] [Abstract][Full Text] [Related]
4. FGFR inhibitor, AZD4547, impedes the stemness of mammary epithelial cells in the premalignant tissues of MMTV-ErbB2 transgenic mice.
Zhao Q; Parris AB; Howard EW; Zhao M; Ma Z; Guo Z; Xing Y; Yang X
Sci Rep; 2017 Sep; 7(1):11306. PubMed ID: 28900173
[TBL] [Abstract][Full Text] [Related]
5. Regulation of tamoxifen sensitivity by a PAK1-EBP1 signalling pathway in breast cancer.
Ghosh A; Awasthi S; Peterson JR; Hamburger AW
Br J Cancer; 2013 Feb; 108(3):557-63. PubMed ID: 23361053
[TBL] [Abstract][Full Text] [Related]
6. Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibition.
Villamar Cruz O; Prudnikova TY; Araiza-Olivera D; Perez-Plasencia C; Johnson N; Bernhardy AJ; Slifker M; Renner C; Chernoff J; Arias-Romero LE
Oncotarget; 2016 Nov; 7(47):76590-76603. PubMed ID: 27740936
[TBL] [Abstract][Full Text] [Related]
7. The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.
Wellberg EA; Johnson S; Finlay-Schultz J; Lewis AS; Terrell KL; Sartorius CA; Abel ED; Muller WJ; Anderson SM
Breast Cancer Res; 2016 Dec; 18(1):131. PubMed ID: 27998284
[TBL] [Abstract][Full Text] [Related]
8. β-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model.
Bui T; Schade B; Cardiff RD; Aina OH; Sanguin-Gendreau V; Muller WJ
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):E707-E716. PubMed ID: 28096336
[TBL] [Abstract][Full Text] [Related]
9. PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma.
Chung EY; Mai Y; Shah UA; Wei Y; Ishida E; Kataoka K; Ren X; Pradhan K; Bartholdy B; Wei X; Zou Y; Zhang J; Ogawa S; Steidl U; Zang X; Verma A; Janakiram M; Ye BH
Clin Cancer Res; 2019 Jun; 25(12):3589-3601. PubMed ID: 30862694
[TBL] [Abstract][Full Text] [Related]
10. Buformin inhibits the stemness of erbB-2-overexpressing breast cancer cells and premalignant mammary tissues of MMTV-erbB-2 transgenic mice.
Parris AB; Zhao Q; Howard EW; Zhao M; Ma Z; Yang X
J Exp Clin Cancer Res; 2017 Feb; 36(1):28. PubMed ID: 28193239
[TBL] [Abstract][Full Text] [Related]
11. P-21 activated kinase 1 knockdown inhibits β-catenin signalling and blocks colorectal cancer growth.
He H; Huynh N; Liu KH; Malcontenti-Wilson C; Zhu J; Christophi C; Shulkes A; Baldwin GS
Cancer Lett; 2012 Apr; 317(1):65-71. PubMed ID: 22100495
[TBL] [Abstract][Full Text] [Related]
12. p21-Activated kinase 3 promotes cancer stem cell phenotypes through activating the Akt-GSK3β-β-catenin signaling pathway in pancreatic cancer cells.
Wu HY; Yang MC; Ding LY; Chen CS; Chu PC
Cancer Lett; 2019 Aug; 456():13-22. PubMed ID: 31051214
[TBL] [Abstract][Full Text] [Related]
13. p-21-Activated kinase 1 mediates gastrin-stimulated proliferation in the colorectal mucosa via multiple signaling pathways.
Huynh N; Yim M; Chernoff J; Shulkes A; Baldwin GS; He H
Am J Physiol Gastrointest Liver Physiol; 2013 Mar; 304(6):G561-7. PubMed ID: 23306081
[TBL] [Abstract][Full Text] [Related]
14. CK1epsilon is required for breast cancers dependent on beta-catenin activity.
Kim SY; Dunn IF; Firestein R; Gupta P; Wardwell L; Repich K; Schinzel AC; Wittner B; Silver SJ; Root DE; Boehm JS; Ramaswamy S; Lander ES; Hahn WC
PLoS One; 2010 Feb; 5(2):e8979. PubMed ID: 20126544
[TBL] [Abstract][Full Text] [Related]
15. Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.
Hallett RM; Kondratyev MK; Giacomelli AO; Nixon AM; Girgis-Gabardo A; Ilieva D; Hassell JA
PLoS One; 2012; 7(3):e33976. PubMed ID: 22470504
[TBL] [Abstract][Full Text] [Related]
16. A Rac1/PAK1 cascade controls β-catenin activation in colon cancer cells.
Zhu G; Wang Y; Huang B; Liang J; Ding Y; Xu A; Wu W
Oncogene; 2012 Feb; 31(8):1001-12. PubMed ID: 21822311
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation.
Yu M; Lin G; Arshadi N; Kalatskaya I; Xue B; Haider S; Nguyen F; Boutros PC; Elson A; Muthuswamy LB; Tonks NK; Muthuswamy SK
Mol Cell Biol; 2012 Oct; 32(19):3913-24. PubMed ID: 22851698
[TBL] [Abstract][Full Text] [Related]
18. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
[TBL] [Abstract][Full Text] [Related]
19. Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis.
Wagh PK; Zinser GM; Gray JK; Shrestha A; Waltz SE
Endocrinology; 2012 Jun; 153(6):2735-46. PubMed ID: 22474186
[TBL] [Abstract][Full Text] [Related]
20. Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents.
Ong CC; Gierke S; Pitt C; Sagolla M; Cheng CK; Zhou W; Jubb AM; Strickland L; Schmidt M; Duron SG; Campbell DA; Zheng W; Dehdashti S; Shen M; Yang N; Behnke ML; Huang W; McKew JC; Chernoff J; Forrest WF; Haverty PM; Chin SF; Rakha EA; Green AR; Ellis IO; Caldas C; O'Brien T; Friedman LS; Koeppen H; Rudolph J; Hoeflich KP
Breast Cancer Res; 2015 Apr; 17(1):59. PubMed ID: 25902869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
